Aespira

Single-use Disposable Dry-powder Inhalers

Health Tech & Life Sciences
Non Active, Dec 2015
Pre-Funding Shdema, Israel Founded 2007
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2007
Headcount
6
HQ
Shdema, Israel
Sector
Health Tech & Life Sciences

About

Aespira is developing a pipeline of inhaler products using generic drugs. Aespira's inhalers help prevent contamination, are simple to use by non-trained patients, and facilitate single-dose or non-chronic usage. The company has developed the ActiveMesh technology, a method of packaging dry-powder drugs within a mesh-based package. The breath-driven beating of this package causes it to sieve and release fine dry-powder particles with diameters in the respirable range. The integration of this technology provides an active dispersion mechanism to a passive inhaler. Aespira is also developing a disposable and hygienic whistle-shaped inhaler devicecalled the resQhaler, which uses the airflow though the device fromthe inhalation action of the patient to efficiently beat the ActiveMesh package. This approach ensures effective breath-synchronized drug delivery with audible confirmation.

Q&A

What is Aespira's primary business?
Aespira is developing a pipeline of single-use disposable dry-powder inhaler products using generic drugs, designed for ease of use and contamination prevention.
What technology has Aespira developed for drug delivery?
Aespira has developed ActiveMesh technology, which involves packaging dry-powder drugs within a mesh-based package. The patient's breath causes the package to sieve and release fine dry-powder particles.
What specific inhaler device is Aespira developing?
Aespira is developing a disposable, hygienic, whistle-shaped inhaler device called the resQhaler, which uses airflow from the patient's inhalation to efficiently beat the ActiveMesh package for breath-synchronized drug delivery with audible confirmation.
What is the current status of Aespira?
Aespira is currently inactive, as of December 2015.
When was Aespira founded?
Aespira was founded in January 2007.
What is Aespira's primary sector?
Aespira's primary sector is Health Tech & Life Sciences.
What is the product stage of Aespira's offerings?
Aespira's products are in the R&D stage.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife SupportPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesHealthcarePatientsConsumers
Business model
B2C

Tags

drug-deliverygeneric-drugsrespiratoryasthmamedical-devicesinhalationtreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2007-1
Employees (exact)6
Status reasonNon Active, Dec 2015